Results

OSE Immunotherapeutics SA

06/11/2019 | Press release | Distributed by Public on 06/10/2019 23:48

OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Use of Tedopi® to Treat Brain Metastasis